| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |